Vanderbilt-Ingram Cancer Center

Dr. David Carbone, Director of Specialized Program of Research Excellence in Lung Cancer at Vanderbilt-Ingram Cancer Center, addresses the smoking stigma associated with lung cancer patients. He is quick to point out that many with lung cancer have never smoked and some did the right thing by quitting a long time ago. He notes that [...]

Barbara Forbes, MSN, keeps a big jar of tar on her desk. The dark, goopy mess is a visual representation of the amount of tar that a smoker will ingest by smoking one pack of cigarettes per day for a year. Forbes is the director of the Smoking Cessation Institute at the Vanderbilt Dayani Center [...]

Dr. Pierre Massion, associate professor of medicine and cancer biology at Vanderbilt-Ingram Cancer Center, explains why it is difficult to detect lung cancer at an early stage. He also describes the Nashville Lung Cancer Screening Trial and how he hopes the study will establish a better screening process. If you are interested in learning more [...]

November is a special month for us to be thankful for our neighbors, family and friends. It is also a time to raise awareness for lung and pancreatic cancers. These cancer types rank in the top five for causing the most cancer-related deaths. Lung cancer being number one and pancreatic cancer ranking number 4 according [...]

Join us for Breathe Deep, a free educational event for lung cancer survivors (on-therapy or post-treatment) and their caregivers. If you received or are currently receiving treatment somewhere other than Vanderbilt, the event is still free for you and your caregiver. You will learn about advancements in lung cancer research and clinical care from Vanderbilt-Ingram [...]

  David Carbone, M.D., Ph.D., professor of Medicine, Cell and Developmental Biology and Cancer Biology, and colleagues from two University of Texas medical centers have been awarded research grants from the LUNGevity Foundation to develop better predictive biomarkers and treatment protocols for non-small cell lung cancer patients. Carbone, who leads the Specialized Program of Research [...]

A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that various non-small cell lung cancer (NSCLC) cells grow at different rates, which may explain why some tumors become resistant to anti-cancer drugs faster than others. Based on the differential growth rates, the study suggests that a change in the timing and dosages [...]

Publication this week of results of the National Lung Screening Trial, which found screening with a type of low-dose CT scan could reduce death from lung cancer by as much as 20 percent, was met with excitement and hope from lung cancer survivors, advocates, caregivers, researchers and doctors. httpv://youtu.be/VLX88TjaUw4 The study, sponsored by the National [...]

Smokers and ex-smokers are at higher risk for developing lung cancer, but researchers still don’t know which individuals are most likely to develop the deadly disease. Now, these high-risk individuals who live in the Nashville area are eligible to participate in the Nashville Lung Cancer Screening Trial, a research project to determine which biomarkers could [...]

Christine Lovly, M.D., Ph.D., a fellow in the Division of Hematology/Oncology at Vanderbilt-Ingram Cancer Center (VICC), has been selected to receive a 2011 Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). The $50,000 grant will help fund Lovly’s research on the molecular mechanisms that alter the effectiveness [...]